Literature DB >> 4441772

Proceedings: Refractoriness in blood platelets: effect of prior exposure to aggregating agents on subsequent aggregation responses.

R J Evans, J L Gordon.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4441772      PMCID： PMC1776818     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  1 in total

1.  Refractory state of platelet aggregation with major operations.

Authors:  J R O'Brien; M Etherington; S Jamieson
Journal:  Lancet       Date:  1971-10-02       Impact factor: 79.321
  1 in total
  3 in total

1.  Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41,468), a selective 5-HT2-receptor antagonist. 1982.

Authors:  F de Clerck; J L David; P A Janssen
Journal:  Agents Actions       Date:  1994-12

2.  Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.

Authors:  F Michal; M Motamed
Journal:  Br J Pharmacol       Date:  1976-02       Impact factor: 8.739

3.  Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist.

Authors:  F de Clerck; J L David; P A Janssen
Journal:  Agents Actions       Date:  1982-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.